NCT05057013 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05057013
Title	A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Cancer Research UK
Indications	colorectal cancer cervical cancer endometrial cancer lung non-small cell carcinoma stomach cancer head and neck squamous cell carcinoma triple-receptor negative breast cancer esophageal cancer hepatocellular carcinoma castration-resistant prostate carcinoma prostate cancer urinary bladder cancer ovarian cancer melanoma pancreatic cancer
Therapies	HMBD-001
Age Groups:	child \| senior \| adult
Covered Countries	GBR

Facility	City	Zip	Country	Details
Royal Marsden NHS Foundation Trust	London	SM2 5PT	United Kingdom	Details
The Christie Hospital	Manchester		United Kingdom	Details
Freeman Hospital, Newcastle	Newcastle		United Kingdom	Details
Churchill Hospital	Oxford	OX3 7LE	United Kingdom	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT05057013Clinical Trial Detail